10% Niacinamide + Kojic Acid Serum
This assessment is based only on publicly available INCI, claims, and test evidence. It is not a full Clean Sheet certification. Full certification requires confidential formula review, exact concentrations, supplier documentation, manufacturing records, packaging compatibility, preservative efficacy, stability, and complete claim validation.


- Post-acne marks and dark spots
- Sensitive skin types
- Your skin is patch-test sensitive to new actives
Rs. 449 - Rs. 699 • Analysed 10 June 2026
Hyperpigmentation and post-inflammatory hyperpigmentation are the most common skin concerns across Fitzpatrick III-V skin tones in India. This serum's multi-mechanism approach, covering melanosome transfer inhibition, tyrosinase inhibition, and melanin reduction, is better suited to persistent PIH than single-active brighteners. It is particularly relevant in India's high UV index environment where sun-induced dark spots are a year-round concern. Use SPF daily to prevent re-darkening. If you have sensitive or reactive skin, patch test for 48 hours before full application since Kojic Acid can cause temporary flushing on reactive skin.
This is a web evidence review, not a Clean Sheet certification. We checked the ingredient list, publicly available test reports, marketing claims, and formula logic using only public information available at the time of review.
At a glance
What was checked
Each claim checked against publicly available evidence: published test reports, the ingredient list, and regulatory data.
Pilgrim explicitly states 10% Niacinamide on the product page.
No Parfum, Fragrance, or scent-use essential oils appear in the published INCI.
Niacinamide at 10% has published literature support for pigmentation reduction, but the other brightening actives are at undisclosed concentrations and no finished-product clinical study is publicly available.
Four mechanistically distinct brightening actives are present in the INCI, but concentrations for three of them are not disclosed, making it impossible to verify that each is present at a working dose.
Score breakdown
Public Evidence Score across 5 pillars. Open any row for the full rationale.
Ingredient SafetyExcellent28/30Clean allergen profile with a fragrance free formula.
All ingredients comply with Indian and international cosmetic regulations. Kojic Acid is approved for face care products and can occasionally cause temporary flushing or mild irritation on reactive or very sensitive skin. This is a known sensitivity consideration rather than a safety violation, and it is not a concern at typical cosmetic concentrations in normal use. Alpha Arbutin is well-tolerated at cosmetic concentrations. Sodium Ascorbyl Phosphate has a strong safety track record. There is no synthetic fragrance, no parabens, and no banned UV filters. Phenoxyethanol is a standard preservative at a low concentration. The formula is suitable for most skin types with patch testing recommended for first-time use of Kojic Acid on reactive skin.
Formula LogicStrong21/25This formula targets skin pigmentation through four different mechanisms simultaneously.
This formula targets skin pigmentation through four different mechanisms simultaneously. Niacinamide blocks the step where melanin moves from pigment-producing cells into skin cells. Kojic Acid and Alpha Arbutin both slow the enzyme that makes melanin, but through different binding mechanisms so they complement each other. Sodium Ascorbyl Phosphate helps reduce melanin that has already formed. Ferulic Acid provides antioxidant support and helps stabilise the vitamin C form. The 10% Niacinamide concentration is confirmed by the brand. Kojic Acid, Alpha Arbutin, Ferulic Acid, and Tranexamic Acid concentrations are not published, which limits verification of whether each brightening active is present at a functionally meaningful level.
Claims EvidenceStrong19/25Good evidence for stated claims based on public information.
The full ingredient list is published on the brand product page and Niacinamide is confirmed at 10%, which is a robust and honest disclosure. Kojic Acid concentration is not disclosed, which is a meaningful gap since the ingredient has a regulatory concentration limit in some markets and consumers with sensitive skin cannot independently assess their personal risk without knowing the dose. Alpha Arbutin, Ferulic Acid, and Tranexamic Acid concentrations are also not stated. No third-party clinical study data has been published for this formula. The fragrance-free status is confirmed by the INCI.
Test TransparencyGrade CFair8/15The brand confirms Niacinamide at 10% and publishes the full ingredient list.
The brand confirms Niacinamide at 10% and publishes the full ingredient list. No lab test report, clinical study, preservative efficacy test, or dermatologist-tested documentation with method details is publicly accessible. The Kojic Acid concentration is undisclosed despite being both a functionally important active and an ingredient with regulatory use limits in several jurisdictions. This is the typical transparency position for Indian skincare brands at this price point.
Consumer ClarityStrong4/5Application instructions and frequency guidance are available on the product page.
Application instructions and frequency guidance are available on the product page. A patch test recommendation for Kojic Acid on sensitive skin is not prominently communicated on the product page, which is a gap for a formula containing an ingredient with a known mild sensitisation profile. Suitability and skin type guidance is present. Layering advice for users stacking this with other actives is absent.
Ingredient list
17 ingredients · INCI order
| Ingredient |
|---|
Aqua |
Niacinamide |
Propanediol |
Glycerin |
Kojic Acid |
Pentylene Glycol |
Sodium Ascorbyl Phosphate |
Alpha Arbutin |
Show all 17 ingredientsShow fewer
Tranexamic Acid |
Allantoin |
Ferulic Acid |
Sodium Hyaluronate |
Hydroxyethylcellulose |
Carbomer |
Sodium Hydroxide |
Phenoxyethanol |
Ethylhexylglycerin |
INCI order as declared on packaging. Position reflects approximate concentration (high to low).
Regulatory screen
Each ingredient mapped against 10 global regulatory authorities
No obvious public red flag found
No obvious public red flag found
No obvious public red flag found
No obvious public red flag found
No obvious public red flag found
No obvious public red flag found
No obvious carcinogenicity flag found
No obvious public red flag found
Not triggered
Not triggered
Flags are based on publicly available INCI only. Not a substitute for full regulatory compliance review.
Claims check
Each marketing claim assessed against publicly available evidence
Pilgrim explicitly states 10% Niacinamide on the product page.
Evidence visible
No Parfum, Fragrance, or scent-use essential oils appear in the published INCI.
Evidence visible
Niacinamide at 10% has published literature support for pigmentation reduction, but the other brightening actives are at undisclosed concentrations and no finished-product clinical study is publicly available.
Mentioned only
Four mechanistically distinct brightening actives are present in the INCI, but concentrations for three of them are not disclosed, making it impossible to verify that each is present at a working dose.
Mentioned only
What would improve this score
Public evidence the brand could provide to close verification gaps
- ○Kojic Acid concentration is not publicly stated. Knowing the percentage would allow consumers with sensitive skin to assess their personal risk and verify the active is present at a functionally meaningful level.
- ○Alpha Arbutin and Tranexamic Acid concentrations are not disclosed. Without these, the four-mechanism brightening claim cannot be fully verified from public data.
- ○Formula pH is not published. Niacinamide stability and preservative efficacy both depend on pH, and disclosure would allow independent verification.
- ○No finished-product clinical study or HRIPT test result is publicly accessible. Published test documentation would substantiate the pigmentation reduction efficacy claims.
This assessment is based only on publicly available INCI, claims, and test evidence. It is not a full Clean Sheet certification. Full certification requires confidential formula review, exact concentrations, supplier documentation, manufacturing records, packaging compatibility, preservative efficacy, stability, and complete claim validation.
Full methodology
- What global regulations say about each ingredient
- What toxicology evidence shows at cosmetic concentrations
- What formula concentration context changes
- What the product format and leave-on contact time changes
- What the stated user group needs
- What published test evidence confirms
- What the brand is claiming vs what evidence supports